ClinicalTrials.Veeva

Menu

Prognostic Prediction of NPC Based on MR Diffusion-weighted Imaging

F

Fifth Affiliated Hospital, Sun Yat-Sen University

Status

Unknown

Conditions

Patients With Nasopharyngeal Carcinoma

Treatments

Other: Observing whether developing distant metastasis or recurrence

Study type

Observational

Funder types

Other

Identifiers

NCT05112510
ZDWY.HYXK.003

Details and patient eligibility

About

The purpose of this study is to explore whether the imaging model based on RESOLVE-DWI sequence can exploiting the heterogeneity of nasopharyngeal carcinoma and indicate the prognosis, so as to provide intervention information for clinical decision-making. All patients were randomly divided into the training group and the validation group. Radiomics features extracted from T2-weighted, DWI, apparent diffusion coefficient (ADC), and contrast- enhanced T1-weighted were used to build a radiomics model. Patients'clinical variables were also obtained to build a clinical model. Model of training cohort was established using cross-validation for nasopharyngeal carcinoma prognosis by machine learning, including Logistics Regression, SVM, KNN, Decision Tree, Random Forest, XGBoost, and then, the model will be verified in the validation cohort. Area under the curve (AUC) of the Machine learning model was used as the main evaluation metric.

Enrollment

125 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients with nasopharyngeal carcinoma diagnosed by pathology;
  2. complete clinical data and MR imaging data;
  3. without radiotherapy, chemotherapy or operation before MR examination.

Exclusion criteria

  1. incomplete follow-up data;
  2. poor image quality and can not be used for analysis;
  3. patients with other tumors in the past or at the same time.

Trial design

125 participants in 2 patient groups

event group
Description:
The patients with nasopharyngeal carcinoma developed distant metastasis or recurrence after standard treatment.
Treatment:
Other: Observing whether developing distant metastasis or recurrence
non-event group
Description:
The patients with nasopharyngeal carcinoma did not develop distant metastasis or recurrence after standard treatment.
Treatment:
Other: Observing whether developing distant metastasis or recurrence

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems